The parameters governing the infection probability function and residual room contaminations were identified as key parameters. To control the Salmonella seroprevalence, efficient measures should therefore aim at these parameters. Moreover, the shedding rate and maternal protective factor also had a major impact. Therefore, further investigation on the protective effect of maternal or post-infection antibodies would be needed. (C)

2009 Elsevier Ltd. All rights reserved.”
“Dysregulated glutamatergic neurotransmission has been strongly implicated in the pathophysiology of schizophrenia (SCZ). Recently, presynaptic modulation of glutamate transmission has been shown to have therapeutic Smad inhibitor promise. We asked whether genetic knockdown of glutaminase (gene GLS1) to reduce glutamatergic transmission presynaptically by slowing the recycling of glutamine to glutamate, would produce a phenotype relevant to SCZ and its treatment. GLS1 heterozygous (GLS1 het) mice showed about a 50% global reduction in glutaminase activity,

and a modest reduction in glutamate levels in brain regions relevant to SCZ pathophysiology, but displayed neither general behavioral abnormalities nor SCZ-associated phenotypes. Functional imaging, measuring regional cerebral GSK621 blood volume, showed hippocampal hypometabolism mainly in the CA1 subregion and subiculum, the inverse of recent clinical imaging findings in prodromal and SCZ patients. GLS1 het mice were less sensitive to the behavioral stimulating effects of amphetamine, showed a reduction in amphetamine-induced striatal dopamine release and in ketamine-induced frontal cortical activation, suggesting that GLS1 het mice are resistant to the effects of these pro-psychotic challenges. Moreover, Cediranib (AZD2171) GLS1 het mice showed clozapine-like potentiation of latent inhibition, suggesting that reduction in glutaminase has antipsychotic-like properties. These observations provide further support for the pivotal role of altered glutamatergic synaptic transmission in the pathophysiology of SCZ, and

suggest that presynaptic modulation of the glutamine-glutamate pathway through glutaminase inhibition may provide a new direction for the pharmacotherapy of SCZ. Neuropsychopharmacology (2009) 34, 2305-2322; doi: 10.1038/npp.2009.58; published online 10 June 2009″
“We define basic networks as the undirected subgraphs with minimal number of units in which the distances (geodesics, minimal path lengths) among a set of selected nodes, which we call seeds, in the original graph are conserved. The additional nodes required to draw the basic network are called connectors. We describe a heuristic strategy to find the basic networks of complex graphs. We also show how the characterization of these networks may help to obtain relevant biological information from highly complex protein-protein interaction data. (C) 2009 Elsevier Ltd. All rights reserved.